A model for genetic complementation controlling the chromosomal abnormalities and loss of heterozygosity formation in cancer

Cytogenetic and Genome Research

Volumn 116, Issue 4, 2007, Pages 235-247

  Nestor, A L ^a   Hollopeter, S L ^a   Matsui, S I ^b   Allison, D ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANEUPLOIDY; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CHI SQUARE TEST; CHROMOSOME NUMBER; COLON CANCER; GENE; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION; GENOME; GLIOMA; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LUNG CANCER; MALE; MODEL; PANCREAS CANCER; PRIORITY JOURNAL; RANK SUM TEST; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTRAL KARYOTYPING; STATISTICAL SIGNIFICANCE; STRUCTURAL CHROMOSOME ABERRATION; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; CELL SURVIVAL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; GENE DOSAGE; GENETIC COMPLEMENTATION TEST; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MODELS, GENETIC; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; SPECTRAL KARYOTYPING; TRANSLOCATION, GENETIC;

EID: 34247107653     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100406     Document Type: Article

References (53)

1. Allison DC, Piantadosi S, Hruban RH, Dooley WC, Fishman EK, et al: DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol 67:151-159 (1998).
2. Anderson GR, Brenner BM, Swede H, Chen N, Henry WM, et al: Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res 61:8274-8283 (2001).
3. Anniko M, Tribukait B, Wersall J: DNA ploidy and cell phase in human pituitary tumors. Cancer 53:1708-1713 (1984).
4. Boland CR, Ricciardiello L: How many mutations does it take to make a tumor? Proc Natl Acad Sci USA 96:14675-14677 (1999).
5. Boveri T: Zur Frage der Entstehung maligner Tumoren (Gustav Fischer Verlag, Jena 1914).
6. Boveri T: The Origin of Malignant Tumors, Translated by Marcella Boveri (Williams and Wilkins, Baltimore 1929).
7. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, et al: Mutations of mitotic checkpoint genes in human cancers. Nature 392:300-303 (1998).
8. Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320:627-633 (1989).
9. Cottier M, Tchirkov A, Perissel B, Giollant M, Campos L, Vago P: Cytogenetic characterization of seven human cancer cell lines by combining G- and R-banding, M-FISH, CGH and chromosome-and locus-specific FISH. Int J Mol Med 14:483-495 (2004).
10. Diserens AC, de Tribolet N, Martin-Achard A, Gaide AC, Schnegg JF, Carrel S: Characterization of an established human malignant glioma cell line:LN-18. Acta Neuropathol 53:21-28 (1981).
11. Donohue JH, Nagorney DM, Grant CS, Tsushima K, Ilstrup DM, Adson MA: Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg 125:237-241 (1990).
12. Duesberg P, Li R, Rasnick D, Rausch C, Willer A, et al: Aneuploidy precedes and segregates with chemical carcinogenesis. Cancer Genet Cytogenet 119:83-93 (2000).
13. Haber DA, Fearon ER: The promise of cancer genetics. Lancet 351 Suppl 2:SII1-8 (1998).
14. Hamming JF, Schelfhout LJ, Cornelisse CJ, van dVCJ, Goslings BM, et al: Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer. World J Surg 12:503-508 (1988).
15. Hanks S, Coleman K, Reid S, Plaja A, Firth H, et al: Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36:1159-1161 (2004).
16. Harnden DG, Taylor AM: Chromosomes and neoplasia. Adv Hum Genet 9:1-70 (1979).
17. Hedley DW, Rugg CA, Gelber RD: Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 47:4729-4735 (1987).
18. Heim S, Mitelman F: Cancer Cytogenetics (Wiley-Liss, New York 1995).
19. Herr A, Grutzmann R, Matthaei A, Artelt J, Schrock E, et al: High-resolution analysis of chromosomal imbalances using the Affymetrix 10K SNP genotyping chip. Genomics 85:392-400 (2005).
20. Hsu T, Moorhead P: Chromosome anomalies in human neoplasms with special reference to the mechanisms of polyploidization and aneuploidization in the Hela strain. Ann NY Acad Sci 63:1083-1094 (1956).
21. Isaka T, Nestor AL, Takada T, Allison DC: Chromosomal variations within aneuploid cancer lines. J Histochem Cytochem 51:1343-1353 (2003).
22. Joensuu H, Klemi PJ: DNA aneuploidy in adenomas of endocrine organs. Am J Pathol 132:145-151 (1988).
23. Joensuu H, Klemi P, Eerola E: DNA aneuploidy in follicular adenomas of the thyroid gland. Am J Pathol 124:373-376 (1986).
24. Joensuu H, Klemi PJ, Alanen KA: Co-existence of two aneuploid stemlines in benign adenomas. A report of three cases with stemline heterogeneity. Virchows Arch Pathol Anat Histopathol 415:175-180 (1989)
25. Johansson B, Mertens F, Mitelman F: Primary vs secondary neoplasia-associated chromosomal abnormalities - balanced rearrangements vs genomic imbalances? Genes Chromosomes Cancer 16:155-163 (1996).
26. Jones DJ, Moore M, Schofield PF: Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Brit J Surg 75:28-33 (1988).
27. Karpf AR, Matsui S: Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res 65:8635-8639 (2005).
28. Kheir SM, Bines SD, Vonroenn JH, Soong SJ, Urist MM, Coon JS: Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann Surg 207:455-461 (1988).
29. Kondrashov AS: Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases. Hum Mutat 21:12-27 (2003).
30. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers. Nature 386:623-627 (1997).
31. Levan A: Chromosomes in cancer tissue. Ann NY Acad Sci 63:774-794 (1956).
32. Levine DS, Sanchez CA, Rabinovitch PS, Reid BJ: Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc Natl Acad Sci USA 88:6427-6431 (1991).
33. Li Z, Meng ZH, Sayeed A, Shalaby R, Ljung BM, Dairkee SH: Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression. Cancer Res 62: 5980-5987 (2002).
34. Loeb LA: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51: 3075-3079 (1991).
35. Makino S: Further evidence favoring the concept of the stem cell in ascites tumors of rats. Ann NY Acad Sci 63:818-830 (1956).
36. Matsui S, Sait S, Jones CA, Nowak N, Gross KW: Rapid localization of transgenes in mouse chromosomes with a combined Spectral Karyotyping/ FISH technique. Mamm Genome 13:680-685 (2002).
37. Matsui S, Faitar SL, Rossi MR, Cowell JK: Application of spectral karyotyping to the analysis of the human chromosome complement of interspecies somatic cell hybrids. Cancer Genet Cytogenet 142:30-35 (2003).
38. Melcher R, Koehler S, Steinlein C, Schmid M, Mueller CR, et al: Spectral karyotype analysis of colon cancer cell lines of the tumor suppressor and mutator pathway. Cytogenet Genome Res 98:22-28 (2002).
39. Nestor AL, Willey J, Allison DC: Tissue culture, cell growth, and analysis, in Souba WW, Wilmore DW (eds): Surgical Research, pp 193-206 (Academic Press, San Diego 2001).
40. Nowell PC: The clonal evolution of tumor cell populations. Science 194:23-28 (1976).
41. Phillips JL, Hayward SW, Wang Y, Vasselli J, Pavlovich C, et al: The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res 61:8143-8149 (2001).
42. Rasnick D: Aneuploidy theory explains tumor formation, the absence of immune surveillance, and the failure of chemotherapy. Cancer Genet Cytogenet 136:66-72 (2002).
43. Ried T, Koehler M, Padilla-Nash H, Schröck E: Chromosome analysis by spectral karyotyping, in Spector D, Goldman R, Leinwand L (eds): Cells: A Laboratory Manual, vol 3: Subcellular Localization of Genes and Their Products, pp 113.111-113.119 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1997).
44. Sandberg AA: Some general cytogenetic aspects of cancer, in Sandberg AA (ed): The Chromosomes in Human Cancer and Leukemia, pp 752-788 (Elsevier Science Publishing, New York 1990).
45. Scott NA, Wieand HS, Moertel CG, Cha SS, Beart RW, Lieber MM: Colorectal cancer Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 122:1375-1379 (1987).
46. Shackney SE, Smith CA, Miller BW, Burholt DR, Murtha K, et al: Model for the genetic evolution of human solid tumors. Cancer Res 49:3344-3354 (1989).
47. Stanbridge EJ: Human tumor suppressor genes. Ann Rev Genet 24:615-657 (1990).
48. Stoler DL, Chen N, Basik M, Kahlenberg MS, Rodriguez-Bigas MA, et al: The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci USA 96: 15121-15126 (1999).
49. Strauss BS: The origin of point mutations in human tumor cells. Cancer Res 52:249-253 (1992).
50. Taylor SR, Blatt J, Costantino JP, Roederer M, Murphy RF: Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma. A 10-year retrospective study. Cancer 62:749-754 (1988).
51. Tsushima K, Nagorney DM, Weiland LH, Lieber MM: The relationship of flow cytometric DNA analysis and clinicopathology in small-intestinal carcinoids. Surgery 105:366-373 (1989).
52. van den Ingh HF, Griffioen G, Cornelisse CJ: Flow cytometric detection of aneuploidy in colorectal adenomas. Cancer Res 45:3392-3397 (1985).
53. Vig BK, Sandberg AA: Aneuploidy incidence and etiology, in Vig BK, Sandberg AA (eds): Aneuploidy, Part A: Incidence and Etiology, pp 415-419 (Alan R. Liss, New York 1987).